Olivier Adotevi

Besancon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 112 publications

Multidimensional immune profiling uncovers biphasic peripheral T-cell dynamics after chemoradiation in patients with locally advanced head and neck cancer.

Multidimensional immune profiling uncovers biphasic peripheral T-cell dynamics after chemoradiation in patients with locally advanced head and neck cancer.

Journal: Oncoimmunology

Published: February 27, 2026

Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines.

Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines.

Journal: Research square

Published: November 24, 2025

Interest of adjuvant and neoadjuvant vaccination in the early stages of cancer.

Interest of adjuvant and neoadjuvant vaccination in the early stages of cancer.

Journal: Critical reviews in oncology/hematology

Published: November 10, 2025

Contribution of a specific panel by flow cytometry for the differential diagnosis of plasmacytoid dendritic cell neoplasms.

Contribution of a specific panel by flow cytometry for the differential diagnosis of plasmacytoid dendritic cell neoplasms.

Journal: Annals of hematology

Published: July 30, 2025

Pivekimab sunirine in blastic plasmacytoid dendritic cell neoplasm: assessing spatial response and unraveling resistance mechanisms.

Pivekimab sunirine in blastic plasmacytoid dendritic cell neoplasm: assessing spatial response and unraveling resistance mechanisms.

Journal: Haematologica

Published: July 10, 2025

Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer.

Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer.

Journal: Science advances

Published: June 27, 2025

Circulating Transcriptome Analysis Finds Gene Signatures and Immune Cell Activation and Abundance Predict Response to Immunotherapy in Bladder Cancer.

Circulating Transcriptome Analysis Finds Gene Signatures and Immune Cell Activation and Abundance Predict Response to Immunotherapy in Bladder Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 20, 2025

Evaluation of dasatinib and ponatinib for the control of CD123 CAR-T cell functionalities.

Evaluation of dasatinib and ponatinib for the control of CD123 CAR-T cell functionalities.

Journal: Molecular therapy. Oncology

Published: June 13, 2025

Efficacy of everolimus in patients with hormone receptor positive, HER2 negative, metastatic breast cancer pretreated with CDK4/6 inhibitors.

Efficacy of everolimus in patients with hormone receptor positive, HER2 negative, metastatic breast cancer pretreated with CDK4/6 inhibitors.

Journal: Breast cancer research : BCR

Published: March 10, 2025

Beneficial effect of resveratrol on T cell oxidative metabolism and anti-tumor function is conditioned by prior in vivo T cell history.

Beneficial effect of resveratrol on T cell oxidative metabolism and anti-tumor function is conditioned by prior in vivo T cell history.

Journal: Molecular therapy. Methods & clinical development

Published: February 07, 2025

Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer.

Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer.

Journal: Journal for immunotherapy of cancer

Published: January 28, 2025

Venetoclax in the Therapeutic Strategy for BPDCN Management.

Venetoclax in the Therapeutic Strategy for BPDCN Management.

Journal: EJHaem

Published: January 09, 2025

Showing 1-12 of 112

Last Updated: 09/26/2026